関連する実験動画
Updated: May 15, 2026

09:04
Detection of Neu1 Sialidase Activity in Regulating TOLL-like Receptor Activation
Published on: September 8, 2010
フォスフォノシチド媒介のアダプター採用制御 トール型受容体シグナル伝達
Jonathan C Kagan1, Ruslan Medzhitov
1Section of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA.
Cell
|June 6, 2006
まとめ
トール型受容体 (TLRs) は,アダプタタンパク質を通じて免疫反応を開始する. この研究は,TIRAPがMyD88をTLR4に勧誘する方法を明らかにし,先天性免疫シグナル伝達経路の重要なステップを明らかにしています.
科学分野:
- 免疫学 免疫学とは
- 細胞生物学 細胞生物学
- 分子生物学は分子生物学である.
背景:
- トール型受容体 (TLR) は,微生物感染を検出する先天性免疫に不可欠です.
- MyD88やTIRAPのようなアダプタータンパク質は,TLRシグナル伝達に不可欠ですが,その正確な役割は不明です.
研究 の 目的:
- TLRシグナリングにおけるTIRAPとMyD88の異なる機能を明らかにする.
- TIRAPとMyD88がトール型受容体4 (TLR4) に誘導されるメカニズムについて説明する.
主な方法:
- TIRAPとMyD88からTLR4.4への採用メカニズムを調査した.
- TIRAP内で,フォスファディチリノシトール4,5-ビスホスファート (PIP2) 結合ドメインを特定しました.
主要な成果:
- TIRAPはPIP2結合ドメインを有し,プラズマ膜へのリクルートメントを媒介する.
- TIRAPは,MyD88を活性化されたTLR4に送信し,下流信号伝導を開始します.
- TLR4信号伝達経路におけるTIRAPとMyD88の異なる役割が実証されました.
結論:
- フォスフォノシチド媒介のアダプター採用は,特定のTLR信号伝導経路を開始する重要なメカニズムです.
- この研究では,TLR4の活性化と免疫応答の開始におけるTIRAPとMyD88の連続的な役割が明らかにされています.
関連する概念動画
Amplifying Signals via Second Messengers
Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Signal Transduction: Overview
Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...
Typically, signal transduction involves three...
Transducer Mechanism: G Protein–Coupled Receptors
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical, 7TM, or...
GPCRs are also called heptahelical, 7TM, or...
Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:

